DB
PACB icon

Dmitry Balyasny’s Pacific Biosciences PACB Stock Holding History

Dmitry Balyasny’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,000
Closed -$111K – 3160
2022
Q2 		$111K Buy
+25,000
New +$152K ﹤0.01% 2269
2016
Q4 		– Sell
-169,023
Closed -$46K – 1449
2016
Q3 		$46K Buy
+169,023
New +$1.41M ﹤0.01% 950

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dmitry Balyasny's PACB Position: Q2 2026 in Review

Dmitry Balyasny increased its Pacific Biosciences (PACB) stake by 117% in Q2 2026, buying an estimated $442K and bringing the position to 564,339 shares worth $948K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Dmitry Balyasny first reported a position in PACB in Q4 2015 and has held it in 17 quarters since. The position peaked at $10.4M in Q1 2019. 222 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Dmitry Balyasny held 564,339 shares of Pacific Biosciences worth $948K as of Q2 2026.
  • Dmitry Balyasny bought 303,801 Pacific Biosciences shares in Q2 2026, an estimated $442K.
  • Pacific Biosciences made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2245 holding.
  • Dmitry Balyasny first reported a position in Pacific Biosciences in Q4 2015 and has held it in 17 quarters since.
  • Dmitry Balyasny's Pacific Biosciences position peaked at $10.4M in Q1 2019.
  • 222 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.